Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agneta von Gegerfelt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Plos One|November 18, 2014
Evaluation of a multivalent vaccine against lymphatic filariasis in rhesus macaque modelGajalakshmi Dakshinamoorthy, Agneta von Gegerfelt, Hanne Andersen, et al.
International Journal for Parasitology|October 6, 2018
Corrigendum to "Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates" [Int. J. Parasitol. 48 (2018) 773-783]Vishal Khatri, Nikhil Chauhan, Kanchan Vishnoi, et al.
International Journal for Parasitology|June 10, 2018
Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primatesVishal Khatri, Nikhil Chauhan, Kanchan Vishnoi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 13, 2010
Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virusAgneta von Gegerfelt, Antonio Valentin, Candido Alicea, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2019
PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral TherapyElena Bekerman, Joseph Hesselgesser, Brian Carr, et al.
Retrovirology|January 18, 2006
RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAsSergey Smulevitch, Jenifer Bear, Candido Alicea, et al.
Journal of Virology|June 16, 2005
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challengeMargherita Rosati, Agneta von Gegerfelt, Patricia Roth, et al.
Vaccine|March 2, 2010
Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefitAntonio Valentin, Agneta von Gegerfelt, Margherita Rosati, et al.
Plos One|October 8, 2013
Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaquesSiddappa N Byrareddy, Mila Ayash-Rashkovsky, Victor G Kramer, et al.
Vaccine|January 4, 2011
Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaquesViraj Kulkarni, Rashmi Jalah, Brunda Ganneru, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|November 18, 2014
Evaluation of a multivalent vaccine against lymphatic filariasis in rhesus macaque modelGajalakshmi Dakshinamoorthy, Agneta von Gegerfelt, Hanne Andersen, et al.
International Journal for Parasitology|October 6, 2018
Corrigendum to "Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates" [Int. J. Parasitol. 48 (2018) 773-783]Vishal Khatri, Nikhil Chauhan, Kanchan Vishnoi, et al.
International Journal for Parasitology|June 10, 2018
Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primatesVishal Khatri, Nikhil Chauhan, Kanchan Vishnoi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 13, 2010
Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virusAgneta von Gegerfelt, Antonio Valentin, Candido Alicea, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2019
PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral TherapyElena Bekerman, Joseph Hesselgesser, Brian Carr, et al.
Retrovirology|January 18, 2006
RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAsSergey Smulevitch, Jenifer Bear, Candido Alicea, et al.
Journal of Virology|June 16, 2005
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challengeMargherita Rosati, Agneta von Gegerfelt, Patricia Roth, et al.
Vaccine|March 2, 2010
Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefitAntonio Valentin, Agneta von Gegerfelt, Margherita Rosati, et al.
Plos One|October 8, 2013
Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaquesSiddappa N Byrareddy, Mila Ayash-Rashkovsky, Victor G Kramer, et al.
Vaccine|January 4, 2011
Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaquesViraj Kulkarni, Rashmi Jalah, Brunda Ganneru, et al.
Pageof 2